Awarded

NHS National Generic Pharmaceuticals Wave 13

Descriptions

Invitation to offer for NHS National Generic Pharmaceuticals Wave 13 Offer reference number: CM/PHG/17/5532 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 28 months, with an option or options to extend (at the Authority's sole discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement: Transition (Everolimus) CESW: 1 March 2022 - 30 September 2023 (19 months) LSNE: 1 March 2022 - 31 January 2023 (11 months) NWLN: 1 March 2022 - 31 January 2023 (11 months) Oral Products plus non-parenterals All Regions: 1 March 2022 - 31 May 2024 (27 months) Hospital Only Products CESW: 1 February 2022 - 30 September 2023 (20 months) LSNE: 1 February 2022 - 31 May 2024 (28 months) NWLN: 1 February 2022 - 31 January 2023 (12 months)

Timeline

Published Date :

19th Jan 2022 3 years ago

Deadline :

26th Jul 2021 3 years ago

Tender Awarded :

1 Supplier

Awarded date :

30th Nov 2021

Contract Start :

1st Feb 2022

Contract End :

31st May 2024

CPV Codes

Let’s Get you Started ✍

Get to see all tender details more briefly

Already have an account ?

Workflows

Status :

Awarded

Assign to :

Tender Progress :

0%

Details

Notice Type :

Open opportunity

Tender Identifier :

IT-378-246-T: 2024 - 001

TenderBase ID :

310724019

Low Value :

£100K

High Value :

£1000K

Region :

North Region

Attachments :

Buyer Information

Address :

Liverpool Merseyside , Merseyside , L13 0BQ

Website :

N/A

Procurement Contact

Name :

Tina Smith

Designation :

Chief Executive Officer

Phone :

0151 252 3243

Email :

tina.smith@shared-ed.ac.uk

Possible Competitors

1 Possible Competitors